References
- 1. Thompson WW, Moore MR, Weintraub E Cheng PY, Jin X, Bridges CB, Bresee JS, Shay DK. Estimating Influenza-Associated Deaths in the United States Am J Public Health. 2009; 99(2):225–230.
- 2. Young SJ, Hee JC, Heung JW, Seong-Heon W, Jin-Soo L, Moon-Hyun C, et al. Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country. J Korean Med Sci. 2011; 26(2): 191–19510.3346/jkms.2011.26.2.191303100121286008
- 3. Zimmerman O, Rogowski O, Aviram G, Mizrahi M, Zeltser D, Justo D, et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infectious Diseases 2010, 10: 28810.1186/1471-2334-10-288295906020920320
- 4. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 361(25): 2493.10.1056/NEJMc090904919923563
- 5. Kalyani1 D, Srikanth Bhatt S, Chitralekha T, Rajarao M, Shankar K. Comorbidities In H1N1 Positive Patients – Hospital Based Study, IOSR Journal of Dental and Medical Sciences. 2016;15:52–55.
- 6. Oh WS, Lee SJ, Lee CS, Hur JA, Hur AC, Park YS, et al. A prediction rule to identify severe cases among adult patients hospitalized with pandemicinfluenza A H1N1)-2009. J Korean Med Sci. 2011 Apr; 26(4): 499–506.10.3346/jkms.2011.26.4.499306956821468256
- 7. Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, Arroyo-Anduiza CI, Gaytán-Martínez JE, Manjarrez-Téllez B, et al. Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico. BMC Res Notes. 2015 Sep 11; 8: 432.10.1186/s13104-015-1349-8456639826362856
- 8. Woo HC, Yun SK, Doo SJ, Ji EK, Kun IK, Hee YS, et al. Outcome of pandemic H1N1 pneumonia: clinical and radiological findings for severity assessment. Korean J Intern Med. 2011; 26: 160–167.10.3904/kjim.2011.26.2.160311084821716592
- 9. Liu L, Zhang RF, Lu HZ, Lu SH, Huang Q, Xiong YY, Xi XH, Zhang ZY. Sixty-two severe and critical patients with 2009 influenza A (H1N1) in Shanghai, China. Chin Med J (Engl). 2011 Jun; 124(11): 1662–6.
- 10. Yokota RT, Skalinski LM, Igansi CN, de Souza LR, Iser BP, Reis PO, et al. Risk factors for death from pandemic (H1N1) 2009, southern Brazil. Emerg Infect Dis. 2011 Aug; 17(8): 1467–71.10.3201/eid1708.101233338155621801625
- 11. Li G, Yilmaz M, Kojicic M, Fernández-Pérez E, Wahab R, Charles Huskins W, et al. Outcome of critically ill patients with influenza virus infection. Journal of Clinical Virology. 2009; 46 (3): 275–278,10.1016/j.jcv.2009.07.015710821719699141
- 12. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004; 292: 1333–1340.10.1001/jama.292.11.133315367555
- 13. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009; 302(17): 1896–902. doi: 10.1001/jama.2009.1583.10.1001/jama.2009.158319887665
- 14. BinSaeed AA. Characteristics of pandemic influenza A (H1N1) infection in patients presenting to a university hospital in Riyadh, Saudi Arabia. Ann Saudi Med. 2010; 30(1): 59–62.10.5144/0256-4947.59377
- 15. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009; 302(17): 1880–7. doi: 10.1001/jama.2009.1536. Epub 2009 Oct.10.1001/jama.2009.153619822626
- 16. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis. 2010May 31; 10: 145.10.1186/1471-2334-10-145289000520513239
- 17. Kumar A, Zarychanski R, Pinto R, Cook D, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009; 302: 1872–9.10.1001/jama.2009.149619822627
- 18. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009; 361: 2507–17.10.1056/NEJMoa090661220007555
- 19. Chen KF, Gaydos C, Rothman RE. Update on emerging infections: news from the Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection—California, April-May, 2009. Ann Emerg Med. 2009; 54(5): 732–6.10.1016/j.annemergmed.2009.09.009
- 20. Cheng VCC, To KKW, Tse H, Hung IFN, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev.2012; 25: 223–63.
- 21. Moa AM, Chughtai AA, Muscatello DJ, Turner RM, MacIntyre CR. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials. Vaccine. 2016 Jul 2. pii: S0264-410X(16)30515-1.
- 22. Sridhar S, Brokstad KA, Cox RJ, et al. Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines. 2015; 3: 373–389.10.3390/vaccines3020373449434426343192
- 23. Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. J Clin Virol. 2016 Jun; 79: 68–73.10.1016/j.jcv.2016.04.00527105315
- 24. Herrmannová K, Trojánek M, Havlíčková M, Jiřincová H, Nagy A, Blechová Z, et al. Clinical and epidemiological characteristics of patients hospitalized with severe influenza in the season 2012–2013. Epidemiol Mikrobiol Imunol. 2014 Feb; 63(1): 4–9.
- 25. Leung CH, Tseng HK, Wang WS, Chiang HT, Wu AY, Liu CP. Clinical characteristics of children and adults hospitalized for influenza virus infection. J Microbiol Immunol Infect. 2014 Dec; 47(6): 518–25.10.1016/j.jmii.2013.06.00223932366
- 26. Viasus D, Marinescu C, Villoslada A, Cordero E, Gálvez-Acebal J, et al. CarratalàJ. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study. J Infect. 2013 Sep; 67(3): 185–93.10.1016/j.jinf.2013.05.006711252523747416